Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,823 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,089 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02857699 | Prospective Observational Study to Investigate the Added Value of the Health Related Quality of Life and Patient Reported Symptoms in the Identification of the Recommended Phase II Dose in Phase I Trials of Molecularly Targeted Therapies.(QoL Phase I) | unknown | — | 250 | Institut CurieOTHER | 1 | Aug 5, 2016 | clinicaltrials |
| NCT00376675 | Methylphenidate in Treating Patients With Fatigue Caused by Cancer | completed | Phase 3 | 148 | Alliance for Clinical Trials in OncologyOTHER |
| 1 |
| Aug 1, 2016 |
| clinicaltrials |
| NCT02627430 | Talazoparib and HSP90 Inhibitor AT13387 in Treating Patients With Metastatic Advanced Solid Tumor or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple Negative Breast Cancer | withdrawn | Phase 1 | 0 | National Cancer Institute (NCI)NIH | 0 | Jul 26, 2016 | clinicaltrials |
| NCT01624467 | A Study of Necitumumab Monotherapy and the QT/QTc Interval in Patient With Advanced Solid Tumors | completed | Phase 2 | 75 | Eli Lilly and CompanyINDUSTRY | 1 | Jul 25, 2016 | clinicaltrials |
| NCT02063230 | To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Patients With Hepatic Impairment and Healthy Subjects | completed | Phase 1 | 32 | AstraZenecaINDUSTRY | 1 | Jul 21, 2016 | clinicaltrials |
| NCT00003130 | Paclitaxel in Treating Women With Recurrent Solid Tumors | completed | Phase 2 | 32 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 19, 2016 | clinicaltrials |
| NCT00058331 | Epoetin Alfa in Treating Anemia in Patients With Solid Tumors | completed | Phase 3 | 365 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 18, 2016 | clinicaltrials |
| NCT00997529 | Mini Allo Stem Cell Transplantation for the Treatment of Solid Tumors(MiniSolid) | completed | N/A | 14 | Beth Israel Deaconess Medical CenterOTHER | 1 | Jul 18, 2016 | clinicaltrials |
| NCT01325558 | A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | 30 | Altor BioScienceINDUSTRY | 1 | Jul 15, 2016 | clinicaltrials |
| NCT00003092 | Paclitaxel in Treating Older Patients With Solid Tumors | completed | Phase 3 | 120 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 14, 2016 | clinicaltrials |
| NCT00003565 | Docetaxel in Treating Patients With Solid Tumors | completed | Phase 2 | 109 | Alliance for Clinical Trials in OncologyOTHER | 3 | Jul 14, 2016 | clinicaltrials |
| NCT00860041 | Acute Pain Caused by Paclitaxel in Patients With Cancer | completed | — | 306 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 14, 2016 | clinicaltrials |
| NCT00003600 | Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy | completed | Phase 3 | 344 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 13, 2016 | clinicaltrials |
| NCT00033605 | Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis | completed | Phase 3 | 130 | Alliance for Clinical Trials in OncologyOTHER | 0 | Jul 13, 2016 | clinicaltrials |
| NCT00075855 | Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors | completed | Phase 3 | 150 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 13, 2016 | clinicaltrials |
| NCT00416481 | Assessing Older Patients With Cancer | completed | — | 93 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 13, 2016 | clinicaltrials |
| NCT00041171 | Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery | withdrawn | Phase 3 | 0 | Alliance for Clinical Trials in OncologyOTHER | 0 | Jul 12, 2016 | clinicaltrials |
| NCT01017640 | Veliparib With or Without Mitomycin C in Treating Patients With Metastatic, Unresectable, or Recurrent Solid Tumors | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | Jul 11, 2016 | clinicaltrials |
| NCT00416637 | Bevacizumab in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 27 | Herbert Hurwitz, MDOTHER | 0 | Jul 7, 2016 | clinicaltrials |
| NCT00006348 | Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment | completed | Phase 3 | 100 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 6, 2016 | clinicaltrials |
| NCT00026195 | Irinotecan in Treating Aging Patients With Solid Tumors | completed | Phase 1 | 140 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 6, 2016 | clinicaltrials |
| NCT00363129 | Vitamin E in Preventing Peripheral Neuropathy Caused by Chemotherapy in Patients Receiving Chemotherapy for Cancer | completed | Phase 3 | 207 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 6, 2016 | clinicaltrials |
| NCT00880191 | Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy | completed | Phase 3 | 430 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 6, 2016 | clinicaltrials |
| NCT01473290 | Probiotic Therapy in Preventing Gastrointestinal Complications in Patients Undergoing Chemotherapy and Pelvic Radiation Therapy | withdrawn | Phase 3 | 0 | Alliance for Clinical Trials in OncologyOTHER | 0 | Jul 6, 2016 | clinicaltrials |
| NCT01090960 | A Study Evaluating the Safety and Tolerability of GDC-0068 in Patients With Refractory Solid Tumors | completed | Phase 1 | 52 | Genentech, Inc.INDUSTRY | 1 | Jul 4, 2016 | clinicaltrials |
| NCT01532011 | Erlotinib in Combination With Pralatrexate in Advanced Malignancies | completed | Phase 1 | 72 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 4, 2016 | clinicaltrials |
| NCT02656849 | BAY 1000394 for MCL-1-, MYC-, and CCNE1-Amplified Tumors | withdrawn | Phase 2 | 0 | Dana-Farber Cancer InstituteOTHER | 1 | Jul 1, 2016 | clinicaltrials |
| NCT00002994 | Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors | completed | Phase 1 | 355 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jun 28, 2016 | clinicaltrials |
| NCT00058357 | Lidocaine Patch in Treating Cancer Patients With Neuropathic Pain After Surgery | completed | Phase 3 | 30 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jun 28, 2016 | clinicaltrials |
| NCT01284192 | Study of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and B-Cell Lymphoma) | completed | Phase 1 | 46 | Astellas Pharma IncINDUSTRY | 1 | Jun 28, 2016 | clinicaltrials |
| NCT00578942 | Allo Non-myeloablative SCT Utilizing Matched Family Member Stem Cells Purged Using Campath | completed | Phase 2 | 48 | David Rizzieri, MDOTHER | 1 | Jun 24, 2016 | clinicaltrials |
| NCT01803503 | Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors | unknown | Phase 2 | 80 | National University Hospital, SingaporeOTHER | 1 | Jun 22, 2016 | clinicaltrials |
| NCT00049023 | Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors | completed | Phase 1 | 27 | O'Dorisio, M SOTHER | 1 | Jun 21, 2016 | clinicaltrials |
| NCT01008904 | Magnesium Oxide in Treating Hot Flashes in Menopausal Women With Cancer | completed | Phase 2 | 31 | Virginia Commonwealth UniversityOTHER | 0 | Jun 21, 2016 | clinicaltrials |
| NCT01431547 | Study of Dalotuzumab Alone and With Ridaforolimus in Pediatric Participants With Advanced Solid Tumors (MK-8669-062 AM1) | completed | Phase 1 | 21 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Jun 17, 2016 | clinicaltrials |
| NCT02122809 | Phase I Study of Chiauranib in Patients With Advanced Solid Tumors | completed | Phase 1 | 18 | Chipscreen Biosciences, Ltd.INDUSTRY | 1 | Jun 17, 2016 | clinicaltrials |
| NCT02805166 | PEG-rhG-CSF in Patients With Malignant Solid Tumors Receiving Chemotherapy | completed | Phase 4 | 420 | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.INDUSTRY | 0 | Jun 17, 2016 | clinicaltrials |
| NCT02076230 | A Phase 1 TH-302 Mass Balance Trial | completed | Phase 1 | 10 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 1 | Jun 10, 2016 | clinicaltrials |
| NCT00036946 | VEGF Trap in Treating Patients With Relapsed or Refractory Solid Tumors or Non-Hodgkin's Lymphoma | completed | Phase 1 | — | Regeneron PharmaceuticalsINDUSTRY | 1 | Jun 3, 2016 | clinicaltrials |
| NCT00045266 | VEGF Trap in Treating Patients With Solid Tumors or Non-Hodgkin's Lymphoma | completed | Phase 1 | — | Regeneron PharmaceuticalsINDUSTRY | 1 | Jun 3, 2016 | clinicaltrials |
| NCT01912222 | Pharmacokinetic Study of Oral IXAZOMIB in Cancer Patients With Liver Dysfunction | completed | Phase 1 | 48 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Jun 2, 2016 | clinicaltrials |
| NCT02020226 | A Cardiac Safety Study of TH-302 in Patients With Advanced Solid Tumors | unknown | Phase 1 | 40 | Threshold PharmaceuticalsINDUSTRY | 1 | Jun 2, 2016 | clinicaltrials |
| NCT00933777 | SORAVE - Sorafenib and Everolimus in Solid Tumors(SORAVE) | completed | Phase 1 | 36 | University of CologneOTHER | 1 | May 25, 2016 | clinicaltrials |
| NCT01349296 | BIBF 1120 and RAD001 in Solid Tumors - Phase I(BARIS) | completed | Phase 1 | 18 | University of CologneOTHER | 1 | May 20, 2016 | clinicaltrials |
| NCT00938457 | Stereotactic Radiation Therapy in Treating Patients With Liver Metastases | terminated | Phase 1 / Phase 2 | 3 | Mayo ClinicOTHER | 1 | May 19, 2016 | clinicaltrials |
| NCT00658658 | Panitumumab in Children With Solid Tumors | completed | Phase 1 | 31 | AmgenINDUSTRY | 1 | May 18, 2016 | clinicaltrials |
| NCT01418677 | An Open-Label Study to Assess the Pharmacokinetics and Safety of HALAVEN in Subjects With Cancer Who Also Have Impaired Renal Function | completed | Phase 1 | 19 | Eisai Inc.INDUSTRY | 1 | May 17, 2016 | clinicaltrials |
| NCT02215850 | Safety Study of SLC-0111 in Subjects With Advanced Solid Tumours | completed | Phase 1 | 24 | Welichem Biotech Inc.INDUSTRY | 1 | May 17, 2016 | clinicaltrials |
| NCT00512460 | RTA 744 Injection in Patients With Leptomeningeal Disease | terminated | Phase 1 | 7 | M.D. Anderson Cancer CenterOTHER | 1 | May 16, 2016 | clinicaltrials |
| NCT01327313 | A Study of EMD525797 in Solid Tumor Patients in Japan | completed | Phase 1 | 27 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 1 | May 13, 2016 | clinicaltrials |
Data updated 24 days agoSource updated Aug 5, 2016source: clinicaltrials